Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
A Friday deadline intensifies a clash between Anthropic and the Pentagon over how its Claude AI models may be used by...
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Nvidia sits at a potential turning point, guided by a history of cycles tied to AI and data centers. This article unf...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
A tight group of U.S.-listed power chip stocks built around silicon carbide and GaN technologies are rallying as elec...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
In a televised address ahead of midterm campaigning, Trump pitched a sweeping SNAP reform as proof of tax-cut gains, ...
Bitcoin surges in early trading after news that Iran postponed strikes. The move highlights how geopolitical headline...
Google reopens mobile real estate listings in a growing pilot, delivering property pages, tour requests and agent con...
Bitcoin’s price moves higher even as on-chain activity lags. The surprising disconnect between bitcoin’s price and ne...